-
Lenvatinib Plus Pembrolizumab Delays Tumor Progression in All Organs vs Sunitinib in Advanced RCC
05 Jun 2024 18:17 GMT
… in all organs vs sunitinib (Sutent) in patients with advanced … organ groups. In the lung tumor group, the median time … lenvatinib and pembrolizumab compared with sunitinib,” Viktor Grünwald, MD, … of patients who received sunitinib,” Grünwald said in conclusion …
-
Research Progress of SGLT2 Inhibitors in Cancer Treatment
23 Jan 2025 10:04 GMT
… (colon cancer), H1792 (lung cancer), PANC-1 (pancreatic cancer … inducing apoptosis.12
Lung Cancer Model
Although direct … gene expression in primary lung cancers and their metastatic … inhibitor empagliflozin ameliorates sunitinib-induced cardiac dysfunction …
-
Consultations For Cancer And ADHD Medicines Close Soon
21 Jan 2025 20:43 GMT
… as Yervoy) for
kidney cancer
sunitinib for kidney
cancer
axitinib (branded …
of advanced non-small cell lung cancer with specific gene
mutations
ceftazidime …
-
Eight-Year Data for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Continue to Demonstrate Longest Survival Benefit vs. Sunitinib Reported in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
22 Jan 2024 22:20 GMT
… seeing sustained benefits over sunitinib in the primary … node positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non–small cell lung cancer, …
-
The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
02 Aug 2022 00:04 GMT
… to 15% of all lung cancers.1 SCLC comprises … chemotherapy for small cell lung cancer. Lung Cancer. 2006;52(3 … sunitinib in patients with relapsed or refractory small cell lung cancer. Lung Cancer … with relapsed small cell lung cancer. Lung Cancer. 2016;96:108– …
-
Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy
10 Jan 2025 18:09 GMT
… cell types within the lung cancer tumor microenvironment. For example … al. Three subtypes of lung cancer fibroblasts define distinct therapeutic … of non-small cell lung cancers via HGF/IGF … avelumab plus axitinib versus sunitinib in sarcomatoid renal cell …
-
HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS® in Lung Cancer
07 Mar 2022 06:00 GMT
… savolitinib plus IMFINZI® versus sunitinib monotherapy versus IMFINZI® … caregivers/lung-cancer-101/types-of-lung-cancer . Accessed … lung cancer – A systematic review and meta-analysis. Lung Cancer 2018 … non-small-cell lung cancers harbouring MET exon …
-
HUTCHMED and AstraZeneca Initiate SACHI Phase III Trial of ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients in China After Progression on EGFR Inhibitor Therapy
24 Nov 2021 01:15 GMT
… ;s lung cancer patients are in China.3 Lung cancer is … savolitinib plus IMFINZI® versus sunitinib monotherapy versus IMFINZI® … caregivers/lung-cancer-101/types-of-lung-cancer . Accessed June … other non-small-cell lung cancers harbouring MET exon …
-
LENVIMA Plus KEYTRUDA Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib
26 May 2023 11:04 GMT
… meaningful OS benefit
versus sunitinib, reducing the risk of … the
superior results versus sunitinib from the primary OS … and ORR
compared to sunitinib. These findings reinforce the … hepatocellular carcinoma, non-small cell lung cancer, RCC,
head and neck …
-
Global Lung Cancer Drugs Market Trends, Strategies, And Opportunities In The Lung Cancer Drugs Market 2021-2030
13 Sep 2021 10:54 GMT
… lung cancer drugs market, lung cancer drugs market share, lung cancer drugs market players, lung cancer … drugs market segments and geographies, lung cancer … Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor ( …
About
© 1995-2025